Ouyang J, Zhang Z, Deng B, Liu J, Wang L, Liu H, Koo S, Chen S, Li Y, Yaremenko AV, et al. Oral drug supply platforms for biomedical purposes. Supplies In the present day; 2023.
Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming limitations to affected person adherence: the case for creating progressive drug supply programs. Nat Rev Drug Disc. 2023;22(5):387–409.
Wu B, Kulkarni Okay, Basu S, Zhang S, Hu M. First-pass metabolism through udp-glucuronosyltransferase: a barrier to oral bioavailability of phenolics. J Pharm Sci. 2011;100(9):3655–81.
Date AA, Hanes J, Ensign LM. Nanoparticles for oral supply: design, analysis and state-of-the-art. J Management Launch. 2016;240:504–26.
Deng B, Liu S, Wang Y, Ali B, Kong N, Xie T, Koo S, Ouyang J, Tao W. Oral nanomedicine: challenges and alternatives. Adv Mater. 2023;1:2306081.
Rautio J, Meanwell NA, Di L, Hageman MJ. The increasing position of prodrugs in up to date drug design and improvement. Nat Rev Drug Disc. 2018;17(8):559–87.
Clas S-D, Sanchez RI, Nofsinger R. Chemistry-enabled drug supply (prodrugs): latest progress and challenges. Drug Disc In the present day. 2014;19(1):79–87.
Matsuoka Okay, Igarashi A, Sato N, Isono Y, Gouda M, Iwasaki Okay, Shoji A, Hisamatsu T. Developments in corticosteroid prescriptions for ulcerative colitis and elements related to long-term corticosteroid use: evaluation utilizing japanese claims knowledge from 2006 to 2016. J Crohn’s Colitis. 2021;15(3):358–66.
Salice M, Rizzello F, Calabrese C, Calandrini L, Gionchetti P. A present overview of corticosteroid use in energetic ulcerative colitis. Exp Rev Gastroenterol Hepatol. 2019;13(6):557–61.
Mikami Y, Tsunoda J, Suzuki S, Mizushima I, Kiyohara H, Kanai T. Significance of 5-aminosalicylic acid intolerance within the medical administration of ulcerative colitis. Digestion. 2023;104(1):58–65.
Louis E, Paridaens Okay, Al Awadhi S, Begun J, Cheon JH, Dignass AU, Magro F, Márquez JR, Moschen AR, Narula N, et al. Modelling the advantages of an optimised therapy technique for 5-asa in mild-to-moderate ulcerative colitis. BMJ Open Gastroenterol. 2022;9(1): 000853.
Sehgal P, Colombel J-F, Aboubakr A, Narula N. Systematic overview: security of mesalazine in ulcerative colitis. Aliment Pharmacol Therap. 2018;47(12):1597–609.
Lichtenstein G, Kamm M. 5-aminosalicylate formulations for the therapy of ulcerative colitis-methods of evaluating launch charges and supply of 5-aminosalicylate to the colonic mucosa. Aliment Pharmacol Therap. 2008;28(6):663–73.
Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro M, Czuber-Dochan W, et al. Ecco tips on therapeutics in ulcerative colitis: medical therapy. J Crohn’s Colitis. 2022;16(1):2–17.
Sands BE, Sandborn WJ, Panaccione R, O’Brien CD, Zhang H, Johanns J, Adedokun OJ, Li Okay, Peyrin-Biroulet L, Van Assche G, et al. Ustekinumab as induction and upkeep remedy for ulcerative colitis. N Engl J Med. 2019;381(13):1201–14.
Taku Okay, Britta S, Chen WS, Ferrante M, Shen B, Bernstein CN, Silvio D, Laurent P-B, Toshifumi H, et al. Ulcerative colitis (primer). Nat Rev. 2020;6:1.
Chaparro M, Gisbert JP. Upkeep remedy choices for ulcerative colitis. Exp Opin Pharmacother. 2016;17(10):1339–49.
Panés J, Alfaro I. New therapy methods for ulcerative colitis. Exp Rev Clin Immunol. 2017;13(10):963–73.
Hu S, Zhao R, Xu Y, Gu Z, Zhu B, Hu J. Orally-administered nanomedicine programs focusing on colon irritation for the therapy of inflammatory bowel illness: newest advances. Journal of Supplies Chemistry B. 2024.
Wang R, Cao S, Bashir MEH, Hesser LA, Su Y, Hong SMC, Thompson A, Culleen E, Sabados M, Dylla NP, et al. Therapy of peanut allergy and colitis in mice through the intestinal launch of butyrate from polymeric micelles. Nat Biomed Eng. 2023;7(1):38–55.
Fardafshari F, Taymouri S, Minaiyan M, Tavakoli N. Getting ready simvastatin nanoparticles by a mix of ph-sensitive and timed-release approaches for the potential therapy of ulcerative colitis. J Biomater Appl. 2022;37(5):859–71.
Yan X, Yang C, Yang M, Ma Y, Zhang Y, Zhang Y, Liu C, Xu Q, Tu Okay, Zhang M. All-in-one theranostic nano-platform based mostly on polymer nanoparticles for bret/fret-initiated bioluminescence imaging and synergistically anti-inflammatory remedy for ulcerative colitis. J Nanobiotechnol. 2022;20(1):99.
Yang C, Sung J, Lengthy D, Alghoul Z, Merlin D. Prevention of ulcerative colitis by autologous metabolite switch from colitogenic microbiota handled with lipid nanoparticles encapsulating an anti-inflammatory drug candidate. Pharmaceutics. 2022;14(6):1233.
Geraili A, Xing M, Mequanint Okay. Design and fabrication of drug-delivery programs towards adjustable launch profiles for personalised therapy. View. 2021;2(5):20200126.
Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cantù L, Nicoli S. Polymeric micelles in drug supply: An perception of the methods for his or her characterization and evaluation in biorelevant situations. J Management Launch. 2021;332:312–36.
Zhang Y, Wu Y, Yan Y, Ma Y, Tu L, Shao J, Tang X, Chen L, Liang G, Yin L. Twin-targeted nanoparticle-in-microparticle system for ulcerative colitis remedy. Adv Healthcare Mater. 2023;12(31):2301518.
Zhang Okay, Zhu L, Zhong Y, Xu L, Lang C, Chen J, Yan F, Li J, Qiu J, Chen Y, et al. Prodrug built-in envelope on probiotics to reinforce goal remedy for ulcerative colitis. Adv Sci. 2023;10(4):2205422.
Peng P, Feng T, Yang X, Nie C, Yu L, Ding R, Zhou Q, Jiang X, Li P. Gastrointestinal microenvironment responsive nanoencapsulation of probiotics and medicines for synergistic remedy of intestinal illnesses. ACS Nano. 2023;17(15):14718–30.
Huckaby JT, Lai SK. Pegylation for enhancing nanoparticle diffusion in mucus. Adv Drug Deliv Rev. 2018;124:125–39.
Maisel Okay, Ensign L, Reddy M, Cone R, Hanes J. Impact of floor chemistry on nanoparticle interplay with gastrointestinal mucus and distribution within the gastrointestinal tract following oral and rectal administration within the mouse. J Management Rel. 2015;197:48–57.
Subramanian DA, Langer R, Traverso G. Mucus interplay to enhance gastrointestinal retention and pharmacokinetics of orally administered nano-drug supply programs. J Nanobiotechnol. 2022;20(1):1–23.
Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug launch. Chem Rev. 2016;116(4):2602–63.
Bohrey S, Chourasiya V, Pandey A. Polymeric nanoparticles containing diazepam: preparation, optimization, characterization, in-vitro drug launch and launch kinetic examine. Nano Convergence. 2016;3(1):1–7.
Son G-H, Lee B-J, Cho C-W. Mechanisms of drug launch from superior drug formulations equivalent to polymeric-based drug-delivery programs and lipid nanoparticles. J Pharmac Make investments. 2017;47:287–96.
Tian B, Liu S, Lu W, Jin L, Li Q, Shi Y, Li C, Wang Z, Du Y. Development of ph-responsive and up-conversion luminescent nayf4: Yb3+/er3+@ sio2@ pmaa nanocomposite for colon focused drug supply. Sci Rep. 2016;6(1):21335.
Tang H, Xiang D, Wang F, Mao J, Tan X, Wang Y. 5-asa-loaded sio2 nanoparticles-a novel drug supply system focusing on remedy on ulcerative colitis in mice. Mol Med Rep. 2017;15(3):1117–22.
Wang N, Shao L, Lu W, Fang W, Zhang Q, Solar L, Gao S, Zhu Q, Chen S, Hu R. 5-aminosalicylic acid ph delicate core-shell nanoparticles focusing on ulcerative colitis. J Drug Del Sci Technol. 2022;74: 103578.
Tang S, Yang R, Gao Y, Zhu L, Zheng S, Zan X. Hydrazone-based amphiphilic brush polymer for quick endocytosis and ros-active drug launch. ACS Macro Lett. 2023;12(5):639–45.
Naren G, Hsu C-W, Li S, Morimoto M, Tang S, Hernando J, Guirado G, Irie M, Raymo FM, Sundén H, et al. An all-photonic full colour rgb system based mostly on molecular photoswitches. Nat Commun. 2019;10(1):3996.
Tang S, Zhang Y, Dhakal P, Ravelo L, Anderson CL, Collins KM, Raymo FM. Photochemical barcodes. J Am Chem Soc. 2018;140(13):4485–8.
Tang S, Zhang Y, Thapaliya ER, Brown AS, Wilson JN, Raymo FM. Highlighting most cancers cells with halochromic switches. ACS Sens. 2017;2(1):92–101.
Pietropaolo A, Tang S, Raymo FM. Free-energy predictions and absorption spectra calculations for supramolecular nanocarriers and their photoactive cargo. Nanoscale. 2017;9(15):4989–94.
Tang S, Donaphon B, Levitus M, Raymo FM. Structural implications on the properties of self-assembling supramolecular hosts for fluorescent visitors. Langmuir. 2016;32(34):8676–87.
Zhang Y, Swaminathan S, Tang S, Garcia-Amorós J, Boulina M, Captain B, Baker JD, Raymo FM. Photoactivatable bodipys designed to watch the dynamics of supramolecular nanocarriers. J Am Chem Soc. 2015;137(14):4709–19.
Swaminathan S, Fowley C, Thapaliya ER, McCaughan B, Tang S, Fraix A, Captain B, Sortino S, Callan JF, Raymo FM. Supramolecular nanoreactors for intracellular singlet-oxygen sensitization. Nanoscale. 2015;7(33):14071–9.
Tang S, Gao Y, Wang W, Wang Y, Liu P, Shou Z, Yang R, Jin C, Zan X, Wang C, et al. Self-report amphiphilic polymer-based drug supply system with ros-triggered drug launch for osteoarthritis remedy. ACS Macro Lett. 2023;13(1):58–64.
Davoudi Z, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Barrett TA, Narasimhan B, Wang Q. Intestinal organoids containing poly (lactic-co-glycolic acid) nanoparticles for the therapy of inflammatory bowel illnesses. J Biomed Mater Res, Half A. 2018;106(4):876–86.
Zhao J, Zhang B, Mao Q, Ping Okay, Zhang P, Lin F, Liu D, Feng Y, Solar M, Zhang Y, et al. Discovery of a colon-targeted azo prodrug of tofacitinib by means of the institution of colon-specific supply programs constructed by 5-asa-paba-mac and 5-asa-paba-diamine for the therapy of ulcerative colitis. J Med Chem. 2022;65(6):4926–48.
Carceller E, Salas J, Merlos M, Giral M, Ferrando R, Escamilla I, Ramis J, García-Rafanell J, Forn J. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating issue antagonist exercise. J Med Chem. 2001;44(18):3001–13.
Kim W, Nam J, Lee S, Jeong S, Jung Y. 5-aminosalicylic acid azo-linked to procainamide acts as an anticolitic mutual prodrug through additive inhibition of nuclear issue kappab. Mol Pharm. 2016;13(6):2126–35.
Jeong S, Lee H, Kim S, Ju S, Kim W, Cho H, Kim HY, Heo G, Im E, Yoo J-W, et al. 5-aminosalicylic acid azo-coupled with a gpr109a agonist is a colon-targeted anticolitic codrug with a lowered threat of pores and skin toxicity. Mol Pharm. 2019;17(1):167–79.
Dutta P, Mukherjee Okay, Saha A, Das A, Badwaik HR, Giri TK. Colonic supply of floor cost embellished nanocarrier for ibd remedy. J Drug Del Sci Technol. 2022;76: 103754.
Guo L, Zhuge Y, Yang L, Qiu H, Liu J, Wang P. A two-photon mitochondria-targeting azo reductase probe for imaging in tumor cells and mice. Dyes Pigm. 2023;218: 111512.
Li J-J, Rong R-X, Yang Y, Hu Z-Y, Hu B, Zhao Y-Y, Li H-B, Hu X-Y, Wang Okay-R, Guo D-S. Triple focusing on host-guest drug supply system based mostly on lactose-modified azocalix [4] arene for tumor ablation. Mater Horizons. 2023;10(5):1689–96.
Hou X, Chang Y-X, Yue Y-X, Wang Z-H, Ding F, Li Z-H, Li H-B, Xu Y, Kong X, Huang F, et al. Supramolecular radiosensitizer based mostly on hypoxia-responsive macrocycle. Adv Sci. 2022;9(6):2104349.
Sangekar S, Vadino W, Chaudry I, Parr A, Beihn R, Digenis G. Analysis of the impact of meals and particular gravity of tablets on gastric retention time. Int J Pharm. 1987;35(3):187–91.
Kedzierewicz F, Thouvenot P, Lemut J, Etienne A, Hoffman M, Maincent P. Analysis of peroral silicone dosage types in people by gamma-scintigraphy. J Management Rel. 1999;58(2):195–205.
Intawongse M, Dean JR. In-vitro testing for assessing oral bioaccessibility of hint metals in soil and meals samples. TrAC, Developments Anal Chem. 2006;25(9):876–86.
Sunesen VH, Vedelsdal R, Kristensen HG, Christrup L, Müllertz A. Impact of liquid quantity and meals consumption on absolutely the bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci. 2005;24(4):297–303.
Roowi S, Stalmach A, Mullen W, Lean ME, Edwards CA, Crozier A. Inexperienced tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by people. J Agric Meals Chem. 2010;58(2):1296–304.
Koyama E, Kitazawa Okay, Ohori Y, Izawa O, Kakegawa Okay, Fujino A, Ui M. In vitro metabolism of the glycosidic sweeteners, stevia combination and enzymatically modified stevia in human intestinal microflora. Meals Chem Toxicol. 2003;41(3):359–74.
Cha KH, Koo SY, Lee D-U. Antiproliferative results of carotenoids extracted from chlorella ellipsoidea and chlorella vulgaris on human colon most cancers cells. J Agric Meals Chem. 2008;56(22):10521–6.
Chevalier A, Renard P-Y, Romieu A. Azo-based fluorogenic probes for biosensing and bioimaging: Latest advances and upcoming challenges. Chemistry. 2017;12(16):2008–28.
Yanai H, Hoshikawa S, Moriiwa Y, Shoji A, Yanagida A, Matsumoto T. A fluorinated carbanionic substituent for bettering water solubility and lipophilicity of fluorescent dyes. Angew Chem. 2021;133(10):5228–32.
Yasukawa Okay, Hirago A, Yamada Okay, Tun X, Ohkuma Okay, Utsumi H. In vivo redox imaging of dextran sodium sulfate-induced colitis in mice utilizing overhauser-enhanced magnetic resonance imaging. Free Radical Biol Med. 2019;136:1–11.
Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (dss)-induced colitis in mice. Curr Prot Immunol. 2014;104(1):15–25.
Hirai F, Matsui T, Aoyagi Okay, Inoue N, Hibi T, Oshitani N, Fujii H, Kobayashi Okay, Suzuki Y, Tanaka S. Validity of exercise indices in ulcerative colitis: comparability of medical and endoscopic indices. Dig Endosc. 2010;22(1):39–44.
Veenstra JP, Vemu B, Tocmo R, Nauman MC, Johnson JJ. Pharmacokinetic evaluation of carnosic acid and carnosol in standardized rosemary extract and the impact on the illness exercise index of dss-induced colitis. Vitamins. 2021;13(3):773.
Kim JJ, Shajib MS, Manocha MM, Khan WI. Investigating intestinal irritation in dss-induced mannequin of ibd. J Visible Exp. 2012;60:3678.
Kim Y, Lim HJ, Jang H-J, Lee S, Jung Okay, Lee SW, Lee S-J, Rho M-C. Portulaca oleracea extracts and their energetic compounds ameliorate inflammatory bowel illnesses in vitro and in vivo by modulating tnf-(alpha), il-6 and il-1(beta) signalling. Meals Res Int. 2018;106:335–43.
Szkaradkiewicz A, Marciniak R, Chudzicka-Strugała I, Wasilewska A, Drews M, Majewski P, Karpiński T, Zwoździak B. Proinflammatory cytokines and il-10 in inflammatory bowel illness and colorectal most cancers sufferers. Archivum immunologiae et therapiae experimentalis. 2009;57:291–4.
Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, et al. Nanoparticle-assembled bioadhesive coacervate coating with extended gastrointestinal retention for inflammatory bowel illness remedy. Nat Commun. 2021;12(1):7162.